Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography
Autor: | James C. Moon, Gorka Bastarrika, Paul Scully, Thomas A. Treibel |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Gadolinium DTPA
medicine.medical_specialty Cardiac PET CT and MRI (F Pugliese and SE Petersen Section Editors) Myocardial Infarction Contrast Media Computed tomography 030204 cardiovascular system & hematology 030218 nuclear medicine & medical imaging Endomyocardial biopsy 03 medical and health sciences 0302 clinical medicine Tissue characterization Fibrosis Extracellular fluid Medicine Humans Heart Failure medicine.diagnostic_test business.industry Surrogate endpoint Myocardium Magnetic resonance imaging Heart Cardiomyopathy Hypertrophic medicine.disease Magnetic Resonance Imaging Extracellular Matrix Diffuse fibrosis cardiovascular system Myocardial fibrosis Cardiovascular magnetic resonance Radiology Cardiology and Cardiovascular Medicine business Tomography X-Ray Computed Extracellular volume |
Zdroj: | Current Cardiology Reports |
ISSN: | 1534-3170 1523-3782 |
Popis: | Purpose of review This review article discusses the evolution of extracellular volume (ECV) quantification using both cardiovascular magnetic resonance (CMR) and computed tomography (CT). Recent findings Visualizing diffuse myocardial fibrosis is challenging and until recently, was restricted to the domain of the pathologist. CMR and CT both use extravascular, extracellular contrast agents, permitting ECV measurement. The evidence base around ECV quantification by CMR is growing rapidly and just starting in CT. In conditions with high ECV (amyloid, oedema and fibrosis), this technique is already being used clinically and as a surrogate endpoint. Non-invasive diffuse fibrosis quantification is also generating new biological insights into key cardiac diseases. Summary CMR and CT can estimate ECV and in turn diffuse myocardial fibrosis, obviating the need for invasive endomyocardial biopsy. CT is an attractive alternative to CMR particularly in those individuals with contraindications to the latter. Further studies are needed, particularly in CT. |
Databáze: | OpenAIRE |
Externí odkaz: |